Diurnal cortisol throughout pregnancy and its association with maternal depressive symptoms and birth outcomes

dc.contributor.authorCastro-Quintas, Águeda
dc.contributor.authorEixarch Roca, Elisenda
dc.contributor.authorSan Martín-Gonzalez, Nerea
dc.contributor.authorDaura-Corral, Maria
dc.contributor.authorMarques-Feixa, Laia
dc.contributor.authorPalma-Gudiel, Helena
dc.contributor.authorRocavert-Barranco, Mireia
dc.contributor.authorMiguel-Valero, Alba
dc.contributor.authorMonteserín-García, José Luis
dc.contributor.authorde la Fuente-Tomás, Lorena
dc.contributor.authorCrispi Brillas, Fàtima
dc.contributor.authorArias Sampériz, Bárbara
dc.contributor.authorGarcía-Portilla González, María Paz, 1962-
dc.contributor.authorFañanás Saura, Lourdes
dc.date.accessioned2025-02-28T18:16:19Z
dc.date.available2025-02-28T18:16:19Z
dc.date.issued2024-03
dc.date.updated2025-02-28T18:16:19Z
dc.description.abstractBackground: Depression during pregnancy is a common complication that can negatively affect fetal health and birth outcomes. Cortisol is believed to be a key mediator of this association. Although pregnancy entails a natural increase in cortisol levels, preclinical depression could alter its circadian rhythm, producing excessively high overall diurnal cortisol levels that might be harmful for the fetus and future offspring development. Objectives: Using a prospective longitudinal design, we aimed to study (i) trimestral cortisol circadian rhythm and its overall levels throughout pregnancy in healthy women, (ii) the extent to which maternal depressive symptoms influence both cortisol rhythmicity and overall levels, and (iii) the possible adverse consequences of elevated maternal cortisol on the offspring’s weight and gestational age at birth. Study design: 112 healthy pregnant women from the general Spanish population were recruited before their first pregnancy. To assess cortisol circadian rhythm, participants provided four saliva samples at each trimester of pregnancy (at awakening, 30 min after awakening, before lunch and before going to bed). Overall cortisol levels were calculated with AUCg approximation. Depressive symptoms were evaluated in each trimester and defined according to EPDS cut-off values (1st trimester, EPDS ≥ 11; 2nd and 3rd trimesters, EPDS ≥ 10). At birth, the risk for low weight, prematurity and weight birth percentile was retrieved for 100 infants. Mixed models and simple effects were employed to study changes of maternal cortisol circadian rhythm and overall levels throughout pregnancy and the possible influence of maternal depressive symptoms. Finally, logistic regressions were performed to assess the associations between maternal overall cortisol levels in each trimester of pregnancy and birth anthropometrics. Results: Although overall diurnal cortisol levels increase throughout pregnancy, cortisol circadian rhythm is preserved in all trimesters [1st (F(3110)= 92.565, p < .001), 2nd (F(3,85)= 46.828, p < .001) and 3rd (F(3,90)= 65.555, p < .001)]. However, women with depressive symptoms showed a flattened cortisol circadian pattern only during the second trimester, characterized by a blunted awakening peak and reduced evening decline (F(3,85)= 4.136, p = .009), but not during the first (F(3,11)= 1.676, p = .176) or the third (F(3,90)= 1.089, p = .358) trimesters. Additionally, they did not show a cortisol increase from second to third trimester (p = .636). Finally, higher maternal cortisol levels in second and third trimesters seemed to be associated with increased risk of prematurity (adjusted OR −0.371, 95% CI 0.490–0.972, p = .034) and low birth weight percentile (adjusted OR −0.612, 95% CI 0.348–0.846, p = .007) respectively. Conclusion: Maternal cortisol levels increased throughout pregnancy, although cortisol circadian rhythm was preserved in all trimesters of pregnancy. However, prenatal depressive symptoms were associated with flattened maternal cortisol circadian rhythm in mid-pregnancy. Therefore, it seems that women with depressive symptoms tended to increase less gradually their cortisol levels from mid to late pregnancy. Finally, higher maternal cortisol levels in mid and late-pregnancy seem to be associated with poorer birth anthropometrics Early detection of depressive symptoms in general population could help to prevent putative obstetrical and birth adverse outcomes.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec741452
dc.identifier.issn0306-4530
dc.identifier.urihttps://hdl.handle.net/2445/219385
dc.language.isoeng
dc.publisherElsevier Ltd.
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.psyneuen.2023.106930
dc.relation.ispartofPsychoneuroendocrinology, 2024, vol. 161, p. 1-10
dc.relation.urihttps://doi.org/10.1016/j.psyneuen.2023.106930
dc.rightscc-by-nc (c) Castro-Quintas, Águeda et al., 2024
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.sourceArticles publicats en revistes (Biologia Evolutiva, Ecologia i Ciències Ambientals)
dc.subject.classificationEmbaràs
dc.subject.classificationHidrocortisona
dc.subject.classificationRitmes circadiaris
dc.subject.classificationPart
dc.subject.otherPregnancy
dc.subject.otherHydrocortisone
dc.subject.otherCircadian rhythms
dc.subject.otherParturition
dc.titleDiurnal cortisol throughout pregnancy and its association with maternal depressive symptoms and birth outcomes
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
839032.pdf
Mida:
2.44 MB
Format:
Adobe Portable Document Format